Dr. Aaronson Gives Kudos To The University of Nebraska for Their Participation in Remdesivir Trial

The National Institute of Health study demonstrated that Remdesivir sped the recovery in patients with advanced coronavirus, also known as COVID-19.

The first trial participant in the ACTT trial was an American who was repatriated after being quarantined on the Diamond Princess cruise ship that docked in Yokohama, Japan, and volunteered to participate in the study at the first study site, the University of Nebraska Medical Center/Nebraska Medicine, in February 2020.

Morrissey: an oracle and "a reasonably good buy."

Interesting drug, the one that you took. Tell the truth! It really helped you, an interesting drug!

Morrissey An Interesting Drug Live on YouTube

Read more about the ACTT Remdesivir trial.